SG11202003550VA - Novel macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same - Google Patents

Novel macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same

Info

Publication number
SG11202003550VA
SG11202003550VA SG11202003550VA SG11202003550VA SG11202003550VA SG 11202003550V A SG11202003550V A SG 11202003550VA SG 11202003550V A SG11202003550V A SG 11202003550VA SG 11202003550V A SG11202003550V A SG 11202003550VA SG 11202003550V A SG11202003550V A SG 11202003550VA
Authority
SG
Singapore
Prior art keywords
same
pharmaceutical compositions
compositions containing
novel macrocyclic
macrocyclic derivatives
Prior art date
Application number
SG11202003550VA
Other languages
English (en)
Inventor
Jérôme-Benoît Starck
Didier Durand
I-Jen Chen
Tiran Arnaud Le
Jean-Claude Ortuno
Miklós Nyerges
Melinda Ligeti
Imre Fejes
Original Assignee
Servier Lab
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Vernalis R&D Ltd filed Critical Servier Lab
Publication of SG11202003550VA publication Critical patent/SG11202003550VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4748Quinolines; Isoquinolines forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533Six-membered rings
    • C07F9/65335Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG11202003550VA 2017-10-25 2018-10-24 Novel macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same SG11202003550VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1760078A FR3072679B1 (fr) 2017-10-25 2017-10-25 Nouveaux derives macrocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/EP2018/079113 WO2019081559A1 (fr) 2017-10-25 2018-10-24 Nouveaux derives macrocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
SG11202003550VA true SG11202003550VA (en) 2020-05-28

Family

ID=61599283

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003550VA SG11202003550VA (en) 2017-10-25 2018-10-24 Novel macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same

Country Status (26)

Country Link
US (1) US11833162B2 (zh)
EP (1) EP3700911B1 (zh)
JP (1) JP7253543B2 (zh)
KR (1) KR102645096B1 (zh)
CN (1) CN111511750B (zh)
AR (1) AR113789A1 (zh)
AU (1) AU2018355709B2 (zh)
BR (1) BR112020007924A2 (zh)
CA (1) CA3080116C (zh)
CL (1) CL2020001073A1 (zh)
CR (1) CR20200169A (zh)
EA (1) EA202090978A1 (zh)
EC (1) ECSP20023535A (zh)
ES (1) ES2963996T3 (zh)
FR (1) FR3072679B1 (zh)
IL (1) IL274141A (zh)
JO (1) JOP20200089A1 (zh)
LT (1) LT3700911T (zh)
MA (1) MA50450B1 (zh)
MX (1) MX2020004345A (zh)
NI (1) NI202000028A (zh)
PE (1) PE20201498A1 (zh)
PH (1) PH12020550448A1 (zh)
SG (1) SG11202003550VA (zh)
TW (1) TWI685498B (zh)
WO (1) WO2019081559A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110256245A (zh) * 2019-06-06 2019-09-20 常州合全药业有限公司 一种4-氯-2-溴苯甲酸叔丁酯的合成方法
KR102589629B1 (ko) 2021-10-06 2023-10-13 한국생명공학연구원 파우시박터 아쿠아틸 유래 신규 화합물 및 이의 용도
WO2023225359A1 (en) 2022-05-20 2023-11-23 Novartis Ag Antibody-drug conjugates of antineoplastic compounds and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2986002B1 (fr) * 2012-01-24 2014-02-21 Servier Lab Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2014022752A1 (en) * 2012-08-03 2014-02-06 Amgen Inc. Macrocycles as pim inhibitors
FR3008979B1 (fr) * 2013-07-23 2015-07-24 Servier Lab Nouveaux derives phosphates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008976A1 (fr) * 2013-07-23 2015-01-30 Servier Lab "nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent"
FR3008975A1 (fr) * 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP3347372A4 (en) * 2015-09-10 2019-09-04 Aileron Therapeutics, Inc. PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1

Also Published As

Publication number Publication date
MX2020004345A (es) 2020-10-14
US11833162B2 (en) 2023-12-05
ECSP20023535A (es) 2020-05-29
EP3700911B1 (fr) 2023-09-06
KR20200077541A (ko) 2020-06-30
KR102645096B1 (ko) 2024-03-06
TW201922754A (zh) 2019-06-16
JOP20200089A1 (ar) 2020-05-03
EP3700911A1 (fr) 2020-09-02
PE20201498A1 (es) 2020-12-29
TWI685498B (zh) 2020-02-21
CA3080116A1 (fr) 2019-05-02
CL2020001073A1 (es) 2020-12-04
AU2018355709A1 (en) 2020-05-07
JP2021500370A (ja) 2021-01-07
EA202090978A1 (ru) 2020-09-07
JP7253543B2 (ja) 2023-04-06
RU2020116154A (ru) 2021-11-25
MA50450A (fr) 2020-09-02
CA3080116C (fr) 2023-01-10
PH12020550448A1 (en) 2021-04-26
BR112020007924A2 (pt) 2020-10-20
CR20200169A (es) 2020-06-14
FR3072679A1 (fr) 2019-04-26
FR3072679B1 (fr) 2020-10-30
AR113789A1 (es) 2020-06-10
IL274141A (en) 2020-06-30
WO2019081559A1 (fr) 2019-05-02
AU2018355709B2 (en) 2023-02-23
RU2020116154A3 (zh) 2022-03-11
LT3700911T (lt) 2023-10-10
US20200253993A1 (en) 2020-08-13
CN111511750B (zh) 2023-06-13
NI202000028A (es) 2020-10-06
ES2963996T3 (es) 2024-04-03
MA50450B1 (fr) 2023-10-31
CN111511750A (zh) 2020-08-07

Similar Documents

Publication Publication Date Title
HK1254656A1 (zh) 新的二環衍生物、其製備方法以及含有它們的藥物組合物
ZA201808286B (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
IL263463B (en) New piperidinyl compounds, a process for their preparation and pharmaceutical preparations containing them
HK1231416A1 (zh) 西羅莫司及其衍生物的絡合物、其製備方法以及含有其的藥物組合物
IL274141A (en) New macrocyclic compounds, a process for their preparation and pharmaceutical preparations containing them
IL279873A (en) History of amino-pyrimidonyl, process for their preparation and pharmaceutical preparations containing them
HRP20190193T1 (hr) Novi derivati fosfanina i azofosfanina,postupak njihove priprave te farmaceutski pripravci koji ih sadrže
IL262489A (en) Complexes of ivacaptor and its salts and their history, a process for their preparation and pharmaceutical preparations containing them
IL262490A (en) Lomacaptor complexes and their salts and derivatives, a process for their preparation and pharmaceutical preparations containing them